WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Stock Ownership - Who owns Lyra Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lyra Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Perceptive Advisors LLC10% Owner2025-11-133,213$3.90
$12.53kSell
Perceptive Advisors LLC10% Owner2025-11-1328,597$3.90
$111.53kSell
Perceptive Advisors LLC10% Owner2025-11-12883$4.06
$3.58kSell
Perceptive Advisors LLC10% Owner2025-11-127,862$4.06
$31.91kSell
Perceptive Advisors LLC10% Owner2025-11-114,783$4.32
$20.64kSell
Perceptive Advisors LLC10% Owner2025-11-11537$4.32
$2.32kSell
Perceptive Advisors LLC10% Owner2025-11-101,869$4.54
$8.49kSell
Perceptive Advisors LLC10% Owner2025-11-1016,633$4.54
$75.51kSell
Perceptive Advisors LLC10% Owner2025-11-071,993$4.75
$9.46kSell
Perceptive Advisors LLC10% Owner2025-11-0717,746$4.75
$84.24kSell

1 of 2

LYRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYRA insiders and whales buy or sell their stock.

LYRA Shareholders

What type of owners hold Lyra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Edward T. Anderson148.76%2,640,228$9.40MInsider
Nbvm GP LLC142.08%2,521,745$8.98MInsider
Perceptive Advisors LLC73.38%1,302,472$4.64MInsider
Maria Palasis61.89%1,098,435$3.91MInsider
Harlan Waksal30.25%536,966$1.91MInsider
Jason Cavalier29.26%519,316$1.85MInsider
Perceptive Advisors LLC12.92%229,382$816.60kInstitution
Soleus Private Equity GP I LLC8.73%155,000$551.80kInsider
Sabby Management LLC7.19%127,624$454.34kInstitution
Carmichael Roberts3.29%58,414$207.95kInsider

1 of 3

LYRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYRA4.75%95.25%Net SellingNet Selling
ADXN0.00%0.00%
CDIO1.49%98.51%
TOVX1.30%0.74%
APRE2.65%97.35%Net BuyingNet Buying
View Top Biotech Stocks

Lyra Therapeutics Stock Ownership FAQ

Who owns Lyra Therapeutics?

Lyra Therapeutics (NASDAQ: LYRA) is owned by 25.28% institutional shareholders, 506.80% Lyra Therapeutics insiders, and 0.00% retail investors. Edward T. Anderson is the largest individual Lyra Therapeutics shareholder, owning 2.64M shares representing 148.76% of the company. Edward T. Anderson's Lyra Therapeutics shares are currently valued at $9.45M.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.